Product
D660
1 clinical trial
1 indication
Indication
HypertensionClinical trial
A Randomized, Double-blind, Multi-center, Therapeutic Confirmatory, Phase 3 Trial To Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy Versus D660 Monotherapy in Essential Hypertension PatientsStatus: Recruiting, Estimated PCD: 2023-08-23